Disease activity (CD5+/CD19+ CLL cells clonally restricted to kappa or lambda) and other immune cell phenotypes, with a principal focus on T cells, were measured by flow cytometry. The gene discussed is CD5; the disease is B-cell chronic lymphocytic leukemia.